In a new statement published on 3 September, the BioMed Alliance calls on the German Council Presidency to guide Member States into adopting a position on the Regulation for Cooperation on Health Technology Assessment (HTA) as soon as possible. The statement also recalls a previous BioMed Alliance statement from 2019 calling for the proposal to swiftly be adopted. Since then, limited progress has been made.
Cooperation on HTA has numerous benefits for the European health system and could enhance coordination, reduce duplication, improve efficiency, reduce costs and lead to better treatments for patients. The coronavirus crisis has illustrated the importance of having a legally sound and functioning HTA system in place that could help the EU to prepare for future health crises. You can read the statement here.
